High CRP Levels and Low Mood: What the Blood Test Really Measures

High CRP levels mark low-grade inflammation in a subgroup of people with depression. That is 27 percent at the 3 mg/L line and 58 percent at 1 mg/L. CRP also rises with infection, injury or a hard workout. So one high value is a reason to repeat the test and look for a cause. It is not a diagnosis.

Three tests get sold as a window into the inflamed gut behind a low mood. They are C-reactive protein, a zonulin panel and a stool microbiome report. One, the test behind high CRP levels, is useful. But it rests on a research cut-off that needs context. One has been shown to detect a different protein than the one on its label. One reads a head count of gut bugs that has rarely held up when repeated.

The video Your Anxiety Is a Fire in Your Gut, from Dr. Gurpreet Singh Padda, MD, MBA, MHP, argues that inflammation born in the first brain can reach the second. The question here is measuring. What do high CRP levels mean for mood? What do they not mean? And what actually repairs the terrain underneath?

What does a high CRP level mean for mood?

Set the line at 1 mg/L and 58 percent of people with depression show raised CRP. At 3 mg/L, the usual line for low-grade inflammation, the share is 27 percent (Osimo et al., 2019). At the 1 mg/L line, the odds of raised CRP in depression were 1.47.

The most useful finding is in the fine print. The share of inflamed patients was not explained by where they were recruited, antidepressant use, age, BMI or ethnicity. It is a real split inside one diagnosis. And no one sees it until someone draws the blood.

Read the number with its limits attached. The 3 mg/L and 5 mg/L lines are research cut-offs. The marker also rises with infection, injury or a hard workout. One high value is a reason to repeat the test and look for a cause, not a diagnosis. That is how hsCRP is read alongside other inflammation biomarkers.

Do anti-inflammatory drugs help depression?

Treatment trials show the split. The largest infliximab trial in treatment-resistant depression gave three infusions over a 12-week study. It made no overall difference. But the people who responded had higher starting TNF and soluble TNF receptor levels (Raison et al., 2013). Pooled across four trials and 152 patients, infliximab still showed no significant benefit. Any gain sat with people who already carried raised inflammation markers.

Adding any anti-inflammatory drug to an antidepressant made response more likely, with a risk ratio of 1.76. But that rests on 341 patients (Köhler-Forsberg et al., 2019). Used alone, the pooled effect came with heterogeneity of 93 percent. That means the trials were not measuring one thing. An average across everyone hides the subgroup a biomarker exists to find. It is the same reason one treatment heals one person and fails another.

The genetic argument that inflammation is a bystander

The strongest case against this model comes from genetics. A Norwegian population study had 68,769 people. Doubling genetically predicted CRP raised a depression symptom score by 2.43 percent. The confidence interval crossed zero (Bekkevold et al., 2023). A UK Biobank analysis of 89,119 people found an interleukin-6 receptor effect. It was real in the statistics and tiny in the clinic, an odds ratio of 1.023.

Those studies measure a lifetime of slightly different genetic set-points. They look at general populations scored by questionnaire. They do not measure inflammation lit by diet, body fat, a leaking gut wall or repeated antibiotics. And they were not run in sick, high-CRP people with metabolic disease. They rule out inflammation as the engine of depression across everyone. They do not rule out the inflamed subgroup. A genetic study inside that group is the one that would change the argument.

Are leaky gut tests accurate?

Zonulin is the marker most leaky-gut panels quote. A widely used commercial ELISA kit was tested in 376 subjects. It did not detect the zonulin precursor named on the label. It seemed to pick up properdin instead (Scheffler et al., 2018). The signal still rises in obesity and diabetes, so it tracks something real. But the name on your report may not match the molecule in the test.

Lipopolysaccharide-binding protein (LBP) marks bacterial fragments reaching the blood. It is more honest about its limits. In 176 adults being checked for sleep apnea, LBP did not differ by depression severity. Yet it did track a blood measure of body-wide inflammation (Gawlik-Kotelnicka et al., 2025). One marker at one point in time is a weak tool for mood. Other researchers measured antibodies instead. Patients with major depression carried more IgM and IgA against gut bacterial endotoxin. The panel told them apart from healthy volunteers with an area under the curve of 90.1% (Maes et al., 2008).

Why a gut microbiome test cannot read your mood

Microbiome reports sell a species list. The research behind them shrinks when repeated. One study had a first group of 1,054 people and a repeat group of 1,539. Overall gut makeup explained almost nothing in the first (R2 = 0.003). It failed outright in the second (Radjabzadeh et al., 2022). Of 24 genera linked to symptoms at first, 12 held up. Genetic testing of direction even leaned toward depression changing one genus, Eggerthella, not the reverse.

Changing the head count does not promise changing the person. In 83 healthy young women, a galacto-oligosaccharide prebiotic raised Bifidobacterium (p = 0.001). Trait anxiety did not differ from placebo (Johnstone & Cohen Kadosh, 2025). The head count is not the activity. A stool test tells you who is present, not what they are doing to you.

What helps when inflammation is behind a low mood?

Bacteria do not ship serotonin to the brain. What a well-fed flora does is turn up your own machinery. In cell culture, 7 of 16 bacterial byproducts raised serotonin output from chromaffin cells. Among them were butyrate, propionate and bile acids. In mice, adding bacteria made existing gut serotonin cells busier without adding new ones. The raw input for much of that is fermentable fiber.

The patients who turn out inflamed tend to carry more than a mood complaint. They bring the high fasting insulin, the widening waist and the upset bowel. They live on a food supply built on cheap flour and sugar. It strips out the fiber a flora needs. Home life counts too. In married couples, more hostile arguments went with higher LBP. That mix is the metaflammation terrain. It is why metabolic inflammation is worked up as one system.

Diet trials back feeding the terrain over swallowing a shortcut. In SMILES, every 10 percent rise in sticking to the diet came with a 2.2-point drop in depression scores. A different trial gave more than a thousand overweight or obese adults daily multinutrient pills for a year. The pills did not prevent major depression (odds ratio 1.06). The pill-only arm had the highest rate, at 12.5 percent (Bot et al., 2019). A pill of nutrients is not a diet.

Four questions to bring to your physician:

• Has my CRP been measured, and was a high value repeated?
• What is my fasting insulin?
• If a zonulin or stool panel was run, what decision will the result change?
• For any supplement, which outcome did the trial pick first, and did that one work?

The full record, including the transplant and nerve-stimulation trials, is in the Chapter 1 Deep Dive. It is the evidence companion to The Angry Gut by Dr. Padda and Ami Michelle Grimes. Start with what stomach acid does to probiotics if you missed it. Then continue to what else is in the pill.

Frequently asked questions

What CRP level counts as high?

It depends on the purpose. Depression research often uses above 3 mg/L to define low-grade inflammation. One infliximab trial saw benefit only above 5 mg/L. Those are research cut-offs on a marker that also rises with infection, injury or hard exercise. So one high result should be repeated and explained before it is treated as a diagnosis. See what a full metabolic audit measures.

Is the zonulin test accurate for leaky gut?

Not as labeled. A widely used commercial zonulin ELISA was tested in 376 subjects. It did not detect the zonulin precursor it names. It seemed to pick up a different protein, properdin. Levels still rise in obesity and diabetes, so the test tracks something real. But do not read its result as a direct measure of gut leakiness. Read what is known about the leaking gut wall.

Can a gut microbiome test diagnose depression or anxiety?

No. The same missing and extra bacterial groups show up across depression, bipolar disorder, schizophrenia and anxiety. Many links shrink once alcohol intake and stool form are counted. A stool report lists which microbes are present, not what they are doing. And results have not held up well across large groups. Explore how the microbiome relates to joint inflammation.

Can inflammation cause depression?

In some people, yes. Healthy volunteers given a small dose of bacterial endotoxin develop a depressed mood. Interferon, an inflammatory treatment, caused major depression in about a quarter of hepatitis C patients. Genetic studies in general populations find only small effects. That fits inflammation driving depression in an inflamed subgroup, not in everyone. Read how the modern plate sets the brain on fire.

Does diet help inflammation-related mood symptoms?

Diet has the strongest treatment evidence here. In a randomized trial of adults with major depression, diet support led to remission far more often than social support. Sticking closer to the diet brought bigger gains. Daily nutrient pills failed to prevent depression in a large European trial. Fiber matters because bacteria turn it into molecules that raise your own serotonin output. Learn how inflammation accelerates aging.

Should I be worried if my CRP is high?

Not from one result alone. CRP rises with infection, injury and even a hard workout. So one high value is a reason to repeat the test and look for a cause, not a diagnosis. If it stays high, it deserves attention. It marks low-grade inflammation. In depression it reveals a real inflamed subgroup that no one sees until someone draws the blood.

How do you fix a high CRP?

Start by finding what is driving it. People whose inflammation shows up this way tend to carry more than one sign: high fasting insulin, a widening waist and an upset bowel. They are often on a diet low in fiber. That is the metabolic inflammation terrain, and it is worked up as one system. Diet has stronger support here than a pill of nutrients, which is not a diet.

Sources

1. Osimo, E. F., Baxter, L. J., Lewis, G., Jones, P. B., & Khandaker, G. M. (2019). Prevalence of low-grade inflammation in depression: A systematic review and meta-analysis of CRP levels. Psychological Medicine, 49(12), 1958–1970. https://doi.org/10.1017/S0033291719001454
2. Raison, C. L., Rutherford, R. E., Woolwine, B. J., Shuo, C., Schettler, P., Drake, D. F., Haroon, E., & Miller, A. H. (2013). A randomized controlled trial of the tumor necrosis factor antagonist infliximab for treatment-resistant depression: The role of baseline inflammatory biomarkers. JAMA Psychiatry, 70(1), 31–41. https://doi.org/10.1001/2013.jamapsychiatry.4
3. Köhler-Forsberg, O., N Lydholm, C., Hjorthøj, C., Nordentoft, M., Mors, O., & Benros, M. E. (2019). Efficacy of anti-inflammatory treatment on major depressive disorder or depressive symptoms: Meta-analysis of clinical trials. Acta Psychiatrica Scandinavica, 139(5), 404–419. https://doi.org/10.1111/acps.13016
4. Bekkevold, O.-J., Damås, J. K., Brumpton, B. M., & Åsvold, B. O. (2023). The causal role of C-reactive protein and interleukin-6 on anxiety and depression symptoms and life satisfaction: Mendelian randomisation analyses in the HUNT study. Psychological Medicine, 53(16), 7561–7568. https://doi.org/10.1017/S0033291723001290
5. Scheffler, L., Crane, A., Heyne, H., Tönjes, A., Schleinitz, D., Ihling, C. H., Stumvoll, M., Freire, R., Fiorentino, M., Fasano, A., Kovacs, P., & Heiker, J. T. (2018). Widely used commercial ELISA does not detect precursor of haptoglobin2, but recognizes properdin as a potential second member of the zonulin family. Frontiers in Endocrinology, 9, 22. https://doi.org/10.3389/fendo.2018.00022
6. Gawlik-Kotelnicka, O., Gabryelska, A., Sochal, M., Czarnecka-Chrebelska, K., Pikus, E., Brzeziańska-Lasota, E., Białasiewicz, P., & Strzelecki, D. (2025). Lipopolysaccharide-binding protein levels, obstructive sleep apnea, and depression: A cross-sectional study of adults. Brain Research, 1856, 149575. https://doi.org/10.1016/j.brainres.2025.149575
7. Maes, M., Kubera, M., & Leunis, J.-C. (2008). The gut-brain barrier in major depression: Intestinal mucosal dysfunction with an increased translocation of LPS from gram negative enterobacteria (leaky gut) plays a role in the inflammatory pathophysiology of depression. Neuro Endocrinology Letters, 29(1), 117–124. https://pubmed.ncbi.nlm.nih.gov/18283240/
8. Radjabzadeh, D., Bosch, J. A., Uitterlinden, A. G., Zwinderman, A. H., Ikram, M. A., van Meurs, J. B. J., Luik, A. I., Nieuwdorp, M., Lok, A., van Duijn, C. M., Kraaij, R., & Amin, N. (2022). Gut microbiome-wide association study of depressive symptoms. Nature Communications, 13(1), 7128. https://doi.org/10.1038/s41467-022-34502-3
9. Johnstone, N., & Cohen Kadosh, K. (2025). A randomised controlled trial of the effects of galacto-oligosaccharides on the gut brain-axis of young females. Brain, Behavior, and Immunity, 129, 573-584. https://doi.org/10.1016/j.bbi.2025.06.020
10. Bot, M., Brouwer, I. A., Roca, M., Kohls, E., Penninx, B. W. J. H., Watkins, E., van Grootheest, G., Cabout, M., Hegerl, U., Gili, M., Owens, M., & Visser, M. (2019). Effect of multinutrient supplementation and food-related behavioral activation therapy on prevention of major depressive disorder among overweight or obese adults with subsyndromal depressive symptoms: The MooDFOOD randomized clinical trial. JAMA, 321(9), 858-868. https://doi.org/10.1001/jama.2019.0556

Medically reviewed by Dr. Gurpreet Singh Padda, MD, MBA, MHP, board certified in anesthesiology, pain medicine, interventional pain management, addiction medicine and obesity medicine. Adapted from Chapter 1 of The Angry Gut by Dr. Padda and Ami Michelle Grimes. Last reviewed September 2026.